Family welcome prosecution of private prison where inmate died of Covid-19
Calum Inglis, 34, was serving a short sentence in HMP Addiewell when he tested positive for Covid-19 on October 12, 2021.
He was asthmatic and unvaccinated, and died on October 24 that year in the West Lothian prison run by Sodexo on behalf of the Scottish Prison Service, after his health deteriorated.
During the 12-day period, he was not seen by a nurse, and reported being breathless and coughing up significant amounts of blood, it was claimed.
It is alleged that in the last four days of his life, he repeatedly requested medical attention via his cell intercom, to be promised by the prison officers that someone would see him in the morning, but nobody came.
On October 24 2021, he was found dead in his cell, and his death was described as 'agonising' by his family's solicitor, Aamer Anwar.
His family spent three-and-a-half years campaigning for an investigation into his death and participated in both the UK Covid-19 Inquiry and the Scottish Covid-19 Inquiry.
On Wednesday, it was announced that a prosecution of HMP Addiewell would take place, after a meeting between the Inglis family and Lord Advocate Dorothy Bain KC at the Crown Office in Edinburgh.
Following the meeting, Mr Anwar said: 'The family are grateful to the Lord Advocate for giving them hope of justice.
'Today she told them that she has instructed a criminal prosecution of Addiewell prison run by Sodexo Ltd and Lothian health board for their alleged failures to properly manage the medical care of Calum Inglis.
'Today is historic, as it will be the first prosecution of a private prison in Scotland, but also one of the first prosecutions relating to 6,000 Covid deaths reported to the Crown Office, including 15 prison deaths.
'Calum was 34 when he contracted Covid as a prisoner at Addiewell prison in October 2021. He was diagnosed with Covid on October 12, 2021.
'On October 24 2021 he was found lying dead, after being left alone to suffer a slow and agonising death.
'Calum was a much-loved son and brother. His family hope that their love for him, the relentless campaign they have fought for him, will leave a lasting legacy.'
Mr Inglis's sister Frances Marr said: 'It is the best news we could have hoped for.'
His father Alan Inglis said: 'It has taken three-and-a-half years to be here. After the meeting with the Lord Advocate, it is apparent that the investigation was very thorough.
'It's a reflection of that, they have all the information they need to go forward. For that we are grateful.'
He said participating in the inquiries had opened up 'a roller-coaster of emotions' and served as a reminder of 'Calum's circumstances and the way he died'.
Speaking previously outside the Scottish Covid-19 Inquiry, Mr Inglis described the situation as 'barbaric', and said: 'Calum was unvaccinated and was asthmatic.
'Within the next 12 days Calum's health would deteriorate rapidly. Throughout this entire period he was not seen by a nurse.
'He reported being breathless and coughing up significant amounts of blood. In the last four days of his life he repeatedly requested medical attention via his cell intercom, to be promised by the prison officers that someone would see him.
'On October 24 2021, two years today, my son was found unresponsive in his cell. He died alone, without help, without dignity.
'The Scottish Covid Inquiry must find out which protocols the prison were following at this time, protocols that would allow such barbaric behaviour to take place, and to examine the staff work culture within that prison where staff must have known how ill my son was, yet did nothing.
'I am looking for accountability and looking to this inquiry to deliver it.'
Ms Bain said: 'I understand the tragic loss felt by Calum's family and their wish to know what happened to him and would like to thank them for meeting with me today to talk about the progress of the investigation.
'I am committed to ensuring that the facts and circumstances surrounding Calum's death are thoroughly investigated by the relevant agencies, fully considered by COPFS and aired in the appropriate legal forum.
'The family and their legal representative will continue to be kept updated in accordance with their wishes.'
A spokesperson at HMP Addiewell said: 'We understand that this continues to be a very difficult time for Mr Inglis's family and our thoughts and condolences remain with them.
'It would be inappropriate to comment further at this stage, but I can confirm that we are continuing to work with all relevant authorities in advance of any future fatal accident inquiry.'
A Scottish Prison Service spokesperson said: 'Our thoughts continue to be with the family and loved ones of Mr Inglis.
'The Scottish Prison Service is fully committed to working with the Scottish Covid Inquiry and supporting it's important work.'
NHS Lothian has been contacted for comment.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
43 minutes ago
- Yahoo
Louisville boy makes medical history as first patient in US with new cochlear implant
DuJuan Broadus couldn't believe how loud the birds outside his bedroom window sounded. The buzzing of the cicadas near his grandmother's home in Georgetown was almost overwhelming. Having unknowingly lived with profound hearing loss for years, the world sounded so much more colorful than the Louisville native ever imagined. In December, DuJuan, now 11, went from having 'the hearing of a World War II veteran,' as one doctor put it, to becoming the first patient in the United States to receive a MED-EL FLEX34 cochlear implant. This new technology is the longest implant on the market and is designed for people, like DuJuan, who have an unusually large cochlea, which is the part of the ear that converts sound vibrations into signals the brain interprets as sound. If doctors had used a shorter model, DuJuan's hearing would have improved, but he wouldn't necessarily have access to such a dynamic range of frequencies, said Dr. Nathan Cass, a UK HealthCare otology and neurotology specialist, who implanted the FLEX34 in DuJuan's ear in December 2024. Specifically, lower, deeper sounds are limited, Cass said. If the electrode can't reach to the end of the patient's cochlea, they'll likely hear voices at a higher pitch. 'They'll say at their (cochlear implant) activation that voices sound kind of like Mickey Mouse,' Cass said. 'But one of the things that this new technology is aiming to try to help is to try to get people to get things to sound more natural.' With the help of the FLEX34, DuJuan now hears the world, and all the background noise that comes with it, at a completely different level. For the past eight months or so, it's been a daily adventure for him to learn and put names to sounds and background noises that his brain had never registered before. 'A lot of times it was really difficult, but I got used to it,' DuJuan told the Courier Journal. 'Now I can tell that the bird is a bird. I can tell a cricket is a cricket. I can tell a motorcycle is a motorcycle.' 'I didn't even know I had hearing loss' The journey to hearing and understanding what the world sounded like started well before DuJuan ended up at UK HealthCare. When DuJuan was about three years old, his parents noticed a speech impediment. His mother has a clear memory of him pointing to a motorcycle as a child, but pronouncing the word for it similar to the name 'Michael.' One of the first lines of intervention with speech is a hearing test. Studies have shown that about one to five children in about every 1,000 has hearing loss, according to the Centers for Disease Control and Prevention. More: Confused about the COVID-19 booster? Here's what children, pregnant women in Kentucky need to know DuJuan passed that first hearing test, and from there, his parents enrolled him in speech therapy. Over time, his speech improved, and he graduated from speech therapy in the third grade. But something still didn't seem right. His grades were strong in reading and math, but his fourth-grade teacher had concerns about how he responded when she spoke to him. She wasn't sure if he didn't understand the question or if he couldn't hear what she was asking. So Jefferson County Public Schools tested him for hearing loss, and this time he failed — dynamically. He was just 10 years old at the time, and was already in severe and profound stages of hearing loss. No one had noticed up until this point, though, because DuJuan is an incredibly bright and resilient child. Without knowing it, DuJuan had taught himself to read lips. He'd become so good at it over the years, that when his mother, Letisha Broadus, spoke to him in the car, he knew to crane his neck up so that he could see her lips moving in the rearview mirror. He thought that this was something that everyone needed to do. 'I didn't even know I had hearing loss at first,' he said. 'Once I knew, I asked my mom 'what is even hearing loss?'' Heartbroken for her son but also determined, Letisha tried to find an ear, nose and throat specialist in Louisville to help. The waitlists locally were months long, so doctors referred her to UK HealthCare's Ear, Nose and Throat Clinic in Lexington, which was ranked No. 37 in the nation by US News and World Report in 2024 for that specialty. The 70-mile trip to the doctors was worth it, if they could schedule a surgery for an implant sooner. In the meantime, DuJuan used a hearing aid, which typically helps patients with low or moderate hearing loss. The day they turned it on in March 2024 was unforgettable for the whole family. 'There were a lot of tears, and a lot of emotions because he could hear things for the first time,' Letisha remembered. When the doctor stapled something to his file, DuJuan's ears caught the quick, snap-like click a stapler makes for the first time, ever. 'Wow,' he told his mom. 'That's what that sounds like.' He had so many things to relearn. 'I wasn't able to stop smiling that day' On the day the Broaduses traveled to Lexington in December 2024 for the cochlear implant surgery, DuJuan was a little nervous, of course, but also excited for what else the implant might help him hear. There are only three companies in the world that manufacture cochlear implants. DuJuan and his parents selected MED-EL, which had released the longest implant currently on the market in 2023. The Food and Drug Administration approved it the July before DuJuan's surgery. DuJuan's cochlea was 38 millimeters long, and he's in the 5-7% of the largest cochleas in the country. It's rare enough that in the eight months that have followed since his surgery, Cass has only implanted one other FLEX34 on a patient. More: Their son died by suicide. Now this Louisville couple is helping other young adults The difference in those extra millimeters, though, is crucial for patients like DuJuan. The cochlea has two fluid-filled chambers lined with tiny hairs. When a sound occurs, it vibrates the fluid in the cochlea. Those impulses are translated into electrical signals that the brain interprets as sound. The farther the implant can reach into the chamber, the more natural the sound becomes in the brain. 'The vast number of sensory cells we have there allows for some of the richness of the sounds that we can understand, and the dynamic range of the frequencies is very large,' Cass explained. When they turned the implant on in the weeks that followed the surgery, DuJuan couldn't wait to hear the world the same way everyone else does. "I wasn't able to stop smiling that day," he remembers. DuJuan is a big fan of music. The hearing aid kept him from having to listen to it on full blast, but now the voices in the songs are clearer. With a shorter implant, the rap music he enjoys might sound like Mickey Mouse is trying to take cues from 50 Cent or Kendrick Lamar. The FLEX34 helps him hear music as everyone else does. Now he has access to lower, bass notes. More: 300 people in line? How hard-to-find bourbons made Buffalo Trace Distillery a cult favorite And that's important, because DuJuan has big plans to join the choir when he starts the sixth grade at Western Middle School for the Arts this school year. He's always been a musically inclined child. When DuJuan was a baby, his mother would sing little songs to him, and he'd somehow managed to reply with the same, proper note. And while he'll have to wait until he's older before his voice lowers enough to hit any bass notes himself — in the meantime, he certainly hears them more on tune than he ever has before. More: What is a cochlear implant? Learn more about device Reach features columnist Maggie Menderski at mmenderski@ Want to learn more? To learn more about cochlear implants, hearing loss, the FLEX34 and other electrodes available for hearing loss patients, visit This article originally appeared on Louisville Courier Journal: Louisville boy first patient in US with med-el-flex34 cochlear implant Solve the daily Crossword
Politico
2 hours ago
- Politico
Will feds weigh in on religious vax carveouts?
Driving the Day RELIGIOUS VAX EXEMPTIONS — It's back-to-school season, which means parents are shuttling their kids to pediatricians for annual checkups — and advocates for and against states' exemptions to vaccine mandates for school entry are gearing up for a fight, Lauren reports. Vaccine skeptics have sought to make their case to the Trump administration's Religious Liberty Commission — created by executive order in May — for executive action to bolster religious carve-outs. But they face pushback from public health experts who warn that more exemptions could threaten public health, setting up another front in the vaccine wars. Four states — California, Connecticut, Maine and New York — don't offer religious exemptions to school vaccine requirements, and Massachusetts lawmakers are considering banning them. West Virginia provides exemptions after GOP Gov. Patrick Morrisey signed an executive order earlier this year invoking the state's religious freedom law. Some religious liberty groups have called on the federal government — which has no say in state vaccine mandates — to use federal education funding as leverage to expand religious opt-outs from school immunization requirements, pointing to a Clinton-era religious protection statute. Precedential web: Some vaccine law experts question how far the executive branch could go to nudge those outlier states toward accepting religious exemptions. The Supreme Court curtailed the Religious Freedom Restoration Act's application to the states in 1997, and administrative conditions on federal funding can't run afoul of Congress' directions. But proponents say those lawyers ignore more recent opinions that work in exemption advocates' favor, pointing to a Covid-19-era decision lifting in-home gathering restrictions on religious grounds and, more recently, the court's ruling in favor of parents who want to opt their children out of LGBTQ+-themed lessons in public schools. Shifting winds: The number of kindergarteners entering school with at least one vaccine exemption continues to tick up, with the CDC reporting last week that 3.6 percent had one in the 2024-2025 school year, compared with 2.2 percent a decade ago. Days before the updated data was released, the American Academy of Pediatrics reaffirmed its opposition to religious exemptions, arguing they should be abolished to protect public health. 'In practice, nonmedical exceptions based on religious belief can substantially limit the public health value of vaccine requirements for school attendance,' the group said in a statement. 'There is no practicable way for schools or other involved community partners to distinguish fairly among religious or other nonmedical claims.' What's next: The Religious Liberty Commission will hold a hearing next month on public education issues, giving exemption proponents another opening to make their case. It's unclear where the White House stands on the concept — a spokesperson didn't comment — but the first Trump administration's HHS pursued avenues to grant health care workers expanded 'conscience' protections and to allow imports of certain vaccines due to some patients' religious beliefs. IT'S TUESDAY. WELCOME BACK TO PRESCRIPTION PULSE. Your host is wondering whether concerns about a common allergy medicine's risks might catch the FDA's attention. Send tips to David Lim (dlim@ @davidalim or davidalim.49 on Signal) and Lauren Gardner (lgardner@ @Gardner_LM or gardnerlm.01 on Signal). Eye on the FDA NEW TOP LAWYER — FDA Commissioner Marty Makary named a longtime government attorney on Monday to be the agency's chief counsel, months after his first pick was torpedoed by Sen. Josh Hawley (R-Mo.). Sean Keveney, who most recently served as HHS's acting general counsel, served as a career civil servant at DOJ's civil rights division before becoming deputy general counsel at HHS in 2019, according to the department and his LinkedIn profile. His predecessor in the position, Hilary Perkins, was also a career DOJ lawyer whose appointment drew Hawley's ire before Makary's confirmation because of her record defending the Biden administration's abortion pill policies. While Perkins also defended the Trump FDA's mifepristone positions, that wasn't enough to overcome his opposition, and she ultimately stepped down days into the job. MDUFA KICKOFF — The FDA's medical device user fee program is not set to expire until Sept. 30, 2027, but the process to renew it has already begun. Despite HHS Secretary Robert F. Kennedy Jr.'s vocal distaste for the user fee programs, the Trump administration has made it clear they are committed to the monthslong process that will likely result in their renewal for another five years. Industry and FDA leaders — including FDA Commissioner Marty Makary and Center for Devices and Radiological Health Director Michelle Tarver — met Monday to discuss the potential sixth iteration of the medical device user fee program. 'While user fees support timeliness and predictability by providing FDA with additional resources, user fees are not a guarantee of approval,' AdvaMed's senior executive vice president, Janet Trunzo, said according to prepared remarks. 'They never have been, and they never should be.' In Congress SENATE PASSES FDA FUNDING — Before leaving town for the August recess, the Senate passed a bill to fund the FDA for fiscal 2026 as part of a minibus package by an 87-9 vote. The legislation, which funds the agency at $7 billion, is made up of $3.6 billion in taxpayer funds and $3.4 billion in user fee revenues. But it is unclear whether lawmakers will have to turn to a continuing resolution before government funding runs out at the end of September. The House Appropriations Committee previously advanced an FDA bill that funded the agency at a lower level. Research Corner BOOST FOR WOMEN'S HEALTH — The Gates Foundation said Monday it would spend $2.5 billion through 2030 to speed global women's research into maternal, menstrual, gynecological and sexual health. Pharma Moves Erika Sward is now chief advocacy officer at UsAgainstAlzheimer's. She previously was assistant vice president of national advocacy at the American Lung Association. Document Drawer FDA Commissioner Marty Makary met with Rep. John Joyce (R-Pa.) for an introductory meeting on July 24. He also met with People for the Ethical Treatment of Animals to discuss nonanimal testing approaches on July 21, according to newly posted public calendar disclosures. He also met with the leadership team of the Government Accountability Office on July 16 to discuss 'items of mutual interest.' WHAT WE'RE READING Top FDA cancer medicine regulator Richard Pazdur played a critical role in the rejection of Replimune Group's skin cancer therapy, STAT's Adam Feuerstein reports. Longevity companies are eyeing Montana as a potential hub for 'biohacking' treatments thanks to state laws embracing patients' 'right-to-try' experimental drugs, The Wall Street Journal's Alex Janin writes.
Newsweek
2 hours ago
- Newsweek
Map Shows States Where COVID Is Rising
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. COVID-19 cases are reported to be rising in 27 states and "likely growing" in 12 states more as well as in Washington D.C., according to the latest data from the U.S. Centers for Disease Control and Prevention (CDC). The national health body warned that COVID-19 infections are estimated to be "growing or likely growing in 40 states [including D.C.], declining or likely declining in zero states, and not changing in nine states," as of July 29. "COVID-19 activity is increasing in many Mid-Atlantic, Southeast, Southern, and West Coast states," the CDC said on August 1. The percentage of positive cases is increasing nationally and while emergency department visits for COVID-19 are low, these visits are rising among all ages. "The current rise in COVID-19 cases is likely multifactorial," Dr. Steven Goldberg, primary care/urgent care physician and chief medical officer at HealthTrackRx—a PCR testing company that works with the CDC to help create fast testing for viruses including COVID-19— told Newsweek. He explained: "Increased summer travel, indoor gatherings due to high temperatures, waning vaccine immunity and the emergence of immune-evasive Omicron subvariants like KP.3 and LB.1 all play a role." "Wastewater surveillance, along with anecdotal reports of increased COVID-19–related ER and urgent care visits, corroborate this increase," Goldberg said. "Notably, real-time transmission estimates (Rt) show values above 1 in most states, indicating active spread." (Rt—the "effective reproduction number"—is an estimate of the average number of new infections caused by each infectious person.) The states with rising cases are each reported to have a more than 90 percent probability that the "COVID-19 epidemic is growing" there. The states with some of the highest probabilities include Florida (99.92 percent), Massachusetts (99.68 percent), Texas (99.52 percent) and Maryland (98.95 percent.) While the current summer wave of cases is less severe than previous peaks, "this surge may intensify further in the fall with back-to-school and return-to-office patterns unless mitigated by vaccine uptake and public awareness," Goldberg warned. The nine states where cases remain unchanged in recent days include Alaska, Hawaii, Idaho, Maine, Montana, Nevada, New Mexico, Rhode Island and Vermont. The percent of emergency department visits in these states was reported to be either low or very low, according to the CDC. According to Goldberg, several factors may explain the plateau in these nine states, including lower population density, such as in Montana and Alaska, as well limited large-scale indoor gatherings, and higher vaccine booster uptake. "It's also possible that regional Rt estimates are slightly lagging and may rise in future updates," he noted. The physician says updated vaccines targeting the latest Omicron sublineages, which are expected to emerge in the fall this year, are "essential" for combating rising cases and new variants. He said: "These next-generation vaccines are designed to enhance protection against immune-evasive strains like the Omicron-subvariants KP.3 and LB.1." Goldberg says that while reinstating broad health mandates may not be necessary at this stage, "targeted recommendations are prudent," noting that supporting voluntary masking in healthcare settings, airports, and high-risk indoor gatherings can help reduce transmission. He advises encouraging vaccination, especially for people at high risk as well as those living with high-risk individuals. Newsweek has contacted the CDC for comment via email and its online media contact form. Do you have a tip on a health story that Newsweek should be covering? Do you have a question about COVID-19? Let us know via health@
